表紙
市場調査レポート

カリニ肺炎:世界の治験レビュー

Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322152
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
カリニ肺炎:世界の治験レビュー Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 80 Pages
概要

当レポートでは、カリニ肺炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • カリニ肺炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:感染症の治験におけるカリニ肺炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症の治験におけるカリニ肺炎の割合

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

カリニ肺炎治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Sanofi
    • GlaxoSmithKline plc
    • U.S. Bioscience, Inc
    • Jacobus Pharmaceutical Company
    • Glaxo Wellcome GmbH & Co. KG
    • AstraZeneca PLC
    • Immtech Pharmaceuticals, Inc.
    • Glaxo Wellcome Operations
    • Abbott Laboratories
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • Peking Union Medical College Hospital
    • Toho University
    • George Washington University
    • University Hospital Hamburg-Eppendorf
    • National Institutes of Health Clinical Center
    • Texas Tech University Health Sciences Center
    • National Cancer Institute

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2493CTIDB

GlobalData's clinical trial report, "Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Pneumocystis Carinii Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pneumocystis Carinii Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pneumocystis Carinii Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pneumocystis Carinii Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pneumocystis Carinii Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • U.S. Bioscience, Inc
      • Clinical Trial Overview of U.S. Bioscience, Inc
      • Jacobus Pharmaceutical Company
      • Clinical Trial Overview of Jacobus Pharmaceutical Company
      • Glaxo Wellcome GmbH & Co. KG
      • Clinical Trial Overview of Glaxo Wellcome GmbH & Co. KG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Immtech Pharmaceuticals, Inc.
      • Clinical Trial Overview of Immtech Pharmaceuticals, Inc.
      • Glaxo Wellcome Operations
      • Clinical Trial Overview of Glaxo Wellcome Operations
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Peking Union Medical College Hospital
      • Clinical Trial Overview of Peking Union Medical College Hospital
      • Toho University
      • Clinical Trial Overview of Toho University
      • George Washington University
      • Clinical Trial Overview of George Washington University
      • University Hospital Hamburg-Eppendorf
      • Clinical Trial Overview of University Hospital Hamburg-Eppendorf
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • Texas Tech University Health Sciences Center
      • Clinical Trial Overview of Texas Tech University Health Sciences Center
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pneumocystis Carinii Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Bioscience, Inc, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Glaxo Wellcome GmbH & Co. KG, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Immtech Pharmaceuticals, Inc., 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Glaxo Wellcome Operations, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking Union Medical College Hospital, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Toho University, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by George Washington University, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Hamburg-Eppendorf, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*

List of Figures

  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Pneumocystis Carinii Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Pneumocystis Carinii Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Pneumocystis Carinii Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top